Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Press release |
08 September 2011
HIV/AIDS

Access to Lifesaving Generic Medicines Threatened by US Trade Pact

Hundreds of Indian activists protested in New Delhi on Monday against a challenge to the country's patent law by Swiss pharmaceutical giant Novartis. Photography by Michel Lotrowska
Press release
Press release |
05 September 2011
Intellectual property and trade
India

Drug company Novartis tries to weaken Indian patent law that protects people

In South Kivu, MSF is running a mass immunization campaign in Fizi health zone that aims to vaccinate 120,000 children between the ages of 6 months and 15 years against measles over a period of six weeks.  This would represent over 90% vaccination coverage for the health zone. Preparations started after a measles epidemic was confirmed at the end of September. Since then MSF has treated around 300 people suffering from measles and its complications. Photograph by Haavar Karlsen
Press release
Press release |
30 August 2011
Intellectual property and trade Vaccines

Democratic Republic of Congo (DRC): Vaccination campaigns must be organised immediately to halt the measles epidemic

Press release |
18 July 2011
HIV/AIDS Intellectual property and trade

Companies Shut Down HIV Drug Discount Programmes In Middle-Income Countries

Catherine Atieno lives with her family in Kibera, a deprived area of the Kenyan capital, Nairobi. Catherine is HIV positive and is being treated at an MSF clinic in Kibera where she also works as a cleaner and a cook. Seven years ago, after she had started antiretroviral treatment, Catherine documented her life in pictures in a project called ÔMy Life with HIVÕ. Photograph by Sven Torfinn
Press release
Press release |
12 July 2011
HIV/AIDS
BrazilIndiaThailand

Gilead Licence Expands Access, But Several Countries Left Out

Press release |
07 July 2011
Tuberculosis

Poor progress means multidrug-resistant tuberculosis continues to spread and cost lives

March against the Free Trade Negotiation between India and the EU. Photograph by MSF
Press release
Press release |
22 June 2011
Intellectual property and trade
India

India Says 'No' to Policy that Would Block Access to Affordable Medicines

Doctors Without Borders/Médecins Sans Frontières (MSF), ACT UP NY, ACT UP Philadelphia, and a coalition of local and national HIV service and advocacy organizations marched on June 8, 2011, the first day of the UN Summit on AIDS. Photograph by Michael Goldfarb
Press release
Press release |
09 June 2011
HIV/AIDS

Target of 15 million people on HIV treatment by 2015 secured at AIDS summit

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury